The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-2399PMID 17047076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipids isolated from bone induce the migration of human breast cancer cells Published, JLR Papers in Press, January 26, 2006.

  2006cited by this paper
• Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.

  2006cited by this paper
• Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration

  2006cited by this paper
• Regulation of carbohydrate metabolism by the farnesoid X receptor.

  2005cited by this paper
• Chronic Inflammation and Breast Pathology: A Theoretical Model

  2005cited by this paper
• Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation.

  2005cited by this paper
• Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer.

  2005cited by this paper
• Suppression of hLRH-1 mediated by a DNA vector-based RNA interference results in cell cycle arrest and induction of apoptosis in hepatocellular carcinoma cell BEL-7402.

  2005cited by this paper
• Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivatives⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional figure. Published, JLR Papers in Press, October 16, 2004. DOI 10.1194/jlr.M400294-JLR200

  2005cited by this paper
• The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene

  2005cited by this paper
• Enterohepatic bile salt transporters in normal physiology and liver disease.

  2004influential reference
• L-leucine transport in human breast cancer cells (MCF-7 and MDA-MB-231): kinetics, regulation by estrogen and molecular identity of the transporter.

  2004cited by this paper
• Bile acid–induced negative feedback regulation of the human ileal bile acid transporter

  2004cited by this paper
• Expression and activation of the farnesoid X receptor in the vasculature.

  2004influential reference
• Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes.

  2004influential reference
• Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3*

  2003cited by this paper
• Bile acid-induced negative feedback regulation of the human ileal bile acid transporter.

  2003influential reference
• A G Protein-coupled Receptor Responsive to Bile Acids*

  2003cited by this paper
• Premenopausal fat intake and risk of breast cancer.

  2003cited by this paper
• Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin.

  2003influential reference
• RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

  2003cited by this paper
• A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.

  2003cited by this paper
• Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis.

  2003influential reference
• Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol

  2003cited by this paper
• Plasma deoxycholic acid concentration is elevated in postmenopausal women with newly diagnosed breast cancer

  2002cited by this paper
• Sensitivity to Anticancer Agents and Resistance Mechanisms in Clear Cell Carcinoma of the Ovary

  2002influential reference
• Transporter Gene Expression in Lactating and Nonlactating Human Mammary Epithelial Cells Using Real-Time Reverse Transcription-Polymerase Chain Reaction

  2002influential reference
• Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor.

  2002influential reference
• Liver Receptor Homologue-1 (LRH-1) Regulates Expression of Aromatase in Preadipocytes*

  2002cited by this paper
• mRNA expression and amino acid transport characteristics of cultured human brain microvascular endothelial cells (hBME).

  2002influential reference
• Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor*

  2002cited by this paper
• Use of dominant negative nuclear receptors to study xenobiotic-inducible gene expression in primary cultured hepatocytes.

  2002cited by this paper
• Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump

  2002cited by this paper
• Expression of Multidrug Resistance‐related Transporters in Human Breast Carcinoma

  2001cited by this paper
• Bile acid transport and regulating functions in the human biliary epithelium

  2001influential reference
• Acute effects of dietary fat composition on postprandial plasma bile acid and cholecystokinin concentrations in healthy premenopausal women

  2001cited by this paper
• The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.

  2001cited by this paper
• Chemical genomics: Functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism

  2001cited by this paper
• Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.

  2001influential reference
• A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

  2000cited by this paper
• Bile acids: natural ligands for an orphan nuclear receptor.

  1999cited by this paper
• Endothelial Cell Apoptosis Induced by the Peroxisome Proliferator-activated Receptor (PPAR) Ligand 15-Deoxy-Δ12,14-prostaglandin J2 *

  1999cited by this paper
• Identification of a nuclear receptor for bile acids.

  1999cited by this paper
• Human hepatocyte growth factor down-regulates the expression of cytochrome P450 isozymes in human hepatocytes in primary culture.

  1998cited by this paper
• Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner).

  1998cited by this paper
• An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors

  1996cited by this paper
• Molecular cloning, expression, and characterization of a human intestinal 15-kDa protein.

  1995influential reference
• Identification of a nuclear receptor that is activated by farnesol metabolites.

  1995cited by this paper
• Breast-gut connection: origin of chenodeoxycholic acid in breast cyst fluid.

  1994cited by this paper
• Bile acids influence the growth, oestrogen receptor and oestrogen-regulated proteins of MCF-7 human breast cancer cells.

  1992cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Role of protein regulators of cholesterol homeostasis in immune modulation and cancer pathophysiology.

  2025cites this paper
• BILE ACIDS IN LIVER AND GASTROINTESTINAL CANCER.

  2025cites this paper
• Therapeutic Advances in Breast Cancer: Clinacanthus nutans as a Source of Bioactive Compounds and Drug Combinations

  2025cites this paper
• Farnesoid X receptor-driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review)

  2025cites this paper
• Role of a Whole Plant Foods Diet in Breast Cancer Prevention and Survival.

  2025cites this paper
• Obeticholic Acid Inhibit Mitochondria Dysfunction Via Regulating ERK1/2‐DRP Pathway to Exert Protective Effect on Lipopolysaccharide‐Induced Myocardial Injury

  2024cites this paper
• The complex landscape of luminal breast cancer.

  2024cites this paper
• The role of the farnesoid X receptor in diabetes and its complications

  2024cites this paper
• Epigenetic Modulations by Microbiome in Breast Cancer.

  2024cites this paper
• FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden

  2024cites this paper
• The Microbiome in the Obesity-Breast Cancer Axis: Diagnostic and Therapeutic Potential

  2023cites this paper
• Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy

  2023cites this paper
• Molecular basis of breast cancer with comorbid depression and the mechanistic insights of Xiaoyaosan in treating breast cancer-associated depression

  2023cites this paper
• The human microbiome: A promising target for lung cancer treatment

  2023cites this paper
• Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies

  2022cites this paper
• Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma

  2022cites this paper
• The role of bile acids in carcinogenesis

  2022cites this paper
• A Presurgical-Window Intervention Trial of Isothiocyanate-Rich Broccoli Sprout Extract in Patients with Breast Cancer.

  2022cites this paper
• Farnesoid X receptor functions in cervical cancer via the p14ARF-mouse double minute 2-p53 pathway

  2022cites this paper
• Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study

  2022cites this paper
• Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway

  2022cites this paper
• Farnesoid X receptor: a potential therapeutic target in multiple organs.

  2021cites this paper
• Regulation of aromatase in cancer

  2021cites this paper
• Exploring the potential of breast microbiota as biomarker for breast cancer and therapeutic response.

  2021cites this paper
• Redox-responsive prodrug for improving oral bioavailability of paclitaxel through bile acid transporter-mediated pathway.

  2021cites this paper
• The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation

  2021cites this paper
• Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells.

  2021cites this paper
• A Review on Phytochemical Composition and Potential Health-promoting Properties of Walnuts

  2021cites this paper
• Characterization and Investigation of Stigmasterol Isolated from Rodent Tuber Mutant Plant (Typhonium flagelliforme), Its Molecular Docking as Anticancer on MF-7 Cells

  2021cites this paper
• Small heterodimer partner as a predictor of neoadjuvant radiochemotherapy response and survival in patients with rectal cancer: A preliminary study

  2021cites this paper
• A pseudo-targeted metabolomics study based on serum bile acids profiling for the differential diagnosis of benign and malignant breast lesions.

  2021cites this paper
• Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer

  2021influential citation
• The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer

  2021influential citation
• Farnesoid X receptor knockout protects brain against ischemic injury through reducing neuronal apoptosis in mice

  2020cites this paper
• The Microbiome as a Component of the Tumor Microenvironment.

  2020cites this paper
• Concentration-dependent effects of sodium cholate and deoxycholate bile salts on breast cancer cells proliferation and survival

  2020cites this paper
• Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity

  2020cites this paper
• Expression of NR1H3 in endometrial carcinoma and its effect on the proliferation of Ishikawa cells in vitro

  2019cites this paper
• Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome

  2019cites this paper
• Circulating primary bile acid is correlated with structural remodeling in atrial fibrillation

  2019cites this paper
• Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects.

  2019cites this paper
• Nonsteroidal FXR Ligands: Current Status and Clinical Applications.

  2019cites this paper
• Differences in the early stage gene expression profiles of lung adenocarcinoma and lung squamous cell carcinoma

  2019cites this paper
• ii Identifying Functional Nuclear Receptor Signaling in Estrogen Receptor-Positive Breast Cancer

  2019cites this paper
• Microbiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored

  2019cites this paper
• CREBZF regulates testosterone production in mouse Leydig cells

  2019cites this paper
• Increased levels of the novel hepatokine fetuin B in patients with intrahepatic cholestasis of pregnancy

  2019cites this paper
• Clinicopathological profiling of small heterodimer partner, as a negative regulator of inflammatory responses in rectal cancer patients

  2019cites this paper
• NcRNAs and Cholangiocarcinoma

  2018cites this paper
• BBA - Molecular Basis of Disease

  2018cites this paper
• Limonene: Aroma of innovation in health and disease.

  2018cites this paper
• On the Evolution of Bile Salts and the Farnesoid X Receptor in Vertebrates

  2018cites this paper
• Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors

  2018cites this paper
• Effects of farnesoid‐X‐receptor SUMOylation mutation on myocardial ischemia/reperfusion injury in mice

  2018cites this paper
• Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts.

  2018cites this paper
• Consumption of Mediterranean versus Western Diet Leads to Distinct Mammary Gland Microbiome Populations

  2018cites this paper
• Farnesoid X Receptor Agonist GW4064 Inhibits Aromatase and ERβ Expression in Human Endometriotic Stromal Cells

  2018cites this paper
• Natural Products to Fight Cancer: A Focus on Juglans regia

  2018cites this paper
• Development of cholate conjugated hybrid polymeric micelles for FXR receptor mediated effective site-specific delivery of paclitaxel

  2018cites this paper
• Clinical significance of farnesoid X receptor expression in thyroid neoplasia.

  2017cites this paper
• Farnesoid X receptor deletion improves cardiac function, structure and remodeling following myocardial infarction in mice

  2017cites this paper
• Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1&agr; binding to HNF4&agr;

  2017cites this paper
• Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations.

  2017cites this paper
• High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinoma.

  2017influential citation
• Bile Acids and Cancer: Direct and Environmental-Dependent Effects.

  2017cites this paper
• Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy Dottoranda:

  2017cites this paper
• Farnesoid X receptor deletion improves cardiac function, structure and remodeling following myocardial infarction in mice

  2017cites this paper
• Gene Expression Profiling Reveals Novel Candidate Markers of Ovarian Carcinoma Intraperitoneal Metastasis

  2017cites this paper
• AWARD NUMBER: W81XWH-14-1-0153 TITLE: Identification of Novel Drug Targets and Lead Compounds for Advanced Prostate Cancer through Genomic and Cheminformatic Analyses PRINCIPAL INVESTIGATOR: Dr. Michael Hsing CONTRACTING ORGANIZATION: UNIVERSITY OF BRITISH COLUMBIA

  2016cites this paper
• Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer

  2016cites this paper
• FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression

  2016cites this paper
• Activation of the Farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential.

  2016cites this paper
• Implication de "Liver X Receptors" dans la physiopathologie des gonades

  2016cites this paper
• Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy

  2016cites this paper
• FXR activation induces mitochondrial mediated apoptosis in breast cancer and synergizes with tamoxifen

  2016cites this paper
• The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

  2016cites this paper
• Liver X receptor as a drug target for the treatment of breast cancer

  2016cites this paper
• Farnesoid X receptor ligand CDCA suppresses human prostate cancer cells growth by inhibiting lipid metabolism via targeting sterol response element binding protein 1.

  2016cites this paper
• Investigation of the inhibitory effects from the Brazilian medicinal plant Pothomorphe umbellata L. (Piperaceae) on the molecular pathways of cyclooxygenase-2 and nuclear factor kappa B

  2016cites this paper
• Elevated Farnesoid X Receptor (FXR) and Retinoid X Receptors (RXRs) expression is associated with less tumor aggressiveness and favourable prognosis in patients with pancreatic adenocarcinoma.

  2015cites this paper
• Tissue-specific actions of FXR in metabolism and cancer.

  2015cites this paper
• ResearchAnti-proliferative effect of LXR agonist T 0901317 in ovarian carcinoma cells

  2015cites this paper
• Pan-cancer analyses of the nuclear receptor superfamily.

  2015cites this paper
• Guggulsterone for Chemoprevention of Cancer.

  2015cites this paper
• Identification of Novel Drug Targets and Lead Compounds for Advanced Prostate Cancer through Genomic and Cheminformatic Analyses

  2015cites this paper
• Puberty-specific promotion of mammary tumorigenesis by a high animal fat diet

  2015cites this paper
• Identification of Novel Drug Targets and Lead Compounds for 5 a . CONTRACT NUMBER Advanced Prostate Cancer through Genomic and Cheminformatic Analyses

  2015cites this paper
• Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors.

  2014influential citation
• Three Measurable and Modifiable Enteric Microbial Biotransformations Relevant to Cancer Prevention and Treatment

  2014cites this paper
• Walnuts have potential for cancer prevention and treatment in mice.

  2014cites this paper
• RETRACTED ARTICLE: MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR

  2014cites this paper
• Nuclear receptors and the Warburg effect in cancer

  2014cites this paper
• Plasma Metabolomic Profiles of Breast Cancer Patients after Short-term Limonene Intervention

  2014cites this paper
• Farnesoid X receptor and reproduction

  2014cites this paper
• Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonists.

  2014cites this paper
• Farnesoid X receptor immunolocalization in reproductive tissues of adult female rabbits.

  2014cites this paper
• What Comes First : The Food or the Nutrient Walnuts Have Potential for Cancer Prevention and Treatment in Mice 1 – 3

  2014cites this paper
• Expressions of farnesoid X receptor and myeloid cell leukemia sequence 1 protein are associated with poor prognosis in patients with gallbladder cancer.

  2014cites this paper
• Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers.

  2014influential citation
• Pharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects?

  2013cites this paper